Skip to content

Monday, February 6, 2023

Latest:

Philosophy, an ancient practice with modern appeal? The role of “big” questions in medical decision-making
Sensitive, rapid tests help to ID estrogen-disrupting chemicals in the environment
Why women with heart issues are undertreated and have worse outcomes than men
Breakthrough epigenetic study can improve the power to predict disease risk
When visible meets invisible: the importance of psychological screening and intervention in pediatric dermatology

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

CDKN2A gene

From The Labs

Exploring the risk of ALL in children with Down syndrome

September 24, 2019September 24, 2019Acute Lymphoblastic Leukemia, ALL, CDKN2A gene, Childhood leukemia, Down syndrome, IKZF1 gene, Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL

From the Labs Image of the Month

From the Labs: Adult-born neurons made the cover